Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PITSTOP: Paramedic Initiated Treatment of Sepsis
NCT03068741Phase 4Completed
- Start
- Mar 2020
- Primary completion
- Nov 2025
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ceftriaxone and sodium chloride in sepsis (4 arms). Primary endpoint: Mortality prior to hospital discharge to day 90. Started Mar 2020; status: completed.
02
Drugs
ceftriaxonesodium chloride
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT03068741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03068741.